cell therapies

Showing 3 posts of 3 posts found.

Bio-Techne opens GMP small-molecule manufacturing facility in Bristol

October 13, 2026
Cardiology, Cleanroom, Diabetes, Haematology, Neurology, Rare Diseases, cell therapies, manufacturing and production, small molecules

Bio-Techne has opened a new facility in Bristol manufacturing Good Manufacturing Practice (GMP)-grade small molecules for cell therapy developers. The …

bayercross3

Bayer buys BlueRock Therapeutics for $600 million

August 9, 2019
Medical Communications Bayer, BlueRock, acquisitions, cell therapies, pharma

Bayer has entered into an agreement to fully acquire engineered cell therapy firm BlueRock Therapeutics in a deal worth $600 …

The Gateway to Local Adoption Series

Latest content





Five Facts about COPD

October 11, 2026